Transient receptor potential cation channel subfamily V member 1 (TRPV1) (TRPV1)

Transient receptor potential cation channel subfamily V member 1 (TRPV1) is a non-selective cation channel primarily expressed in the nociceptive neurons of the peripheral nervous system (UniProt P53767). It acts as a critical molecular integrator of various painful stimuli, including noxious heat, acidic pH, and pungent vanilloid compounds like capsaicin. The physiological process of 'nerve desensitization' is most commonly associated with the prolonged activation of this receptor, which leads to a massive influx of calcium ions. This influx triggers biochemical pathways that cause the temporary retraction of nerve endings or a loss of responsiveness, effectively reducing pain transmission in patients with chronic or neuropathic conditions (PubMed: 28841432). In clinical practice, high-concentration capsaicin patches are utilized to induce this desensitization for the treatment of postherpetic neuralgia and peripheral neuropathic pain. While agonists exploit the desensitization mechanism, antagonists have also been developed to block the receptor directly; however, many early clinical trials for antagonists faced challenges due to side effects like impaired thermoregulation and hyperthermia (StatPearls: Capsaicin). Understanding the structural dynamics of TRPV1 is vital for biotech development, as it remains a validated target for pain management and inflammatory disease therapies.

Other names

Vanilloid receptor 1VR1Capsaicin receptorOSRC

TRPV1 agonists (e.g., capsaicin) cause initial excitation of nociceptive fibers followed by a refractory period known as 'desensitization' or 'defunctionalization,' where the nerve endings become unresponsive to various stimuli due to calcium-dependent protease activation and microtubule disassembly (StatPearls, 2023). Alternatively, TRPV1 antagonists block the channel's activation by inflammatory mediators or heat to prevent pain signaling.